Bridge to Life Ltd.: Funding, Investors & Team (Oct 2026)
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. The U.S. based company, headquartered in Northbrook, Illinois, is a leading supplier of preservation solutions worldwide with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, it continues to explore emerging science and preservation technologies.
Bridge to Life Ltd. has raised $166M across 2 funding rounds on record, the most recent a Series C of $110M announced in Aug 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bridge to Life Ltd. Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Bridge to Life Ltd. Funding Rounds
Bridge to Life Ltd. raised $56.0M in an undisclosed round announced in Aug 2021.
5 years later, a Series C of $110M was announced in Aug 2026.
Bridge to Life Ltd. Investors
Bridge to Life Ltd. Founders and Leadership Team
Contact details for the Bridge to Life Ltd. team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Bridge to Life Ltd. Funding Compared to Other Biotechnology Startups
Bridge to Life Ltd.'s latest round of $110M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bridge to Life Ltd. in Biotechnology and Northbrook
Companies Similar to Bridge to Life Ltd.
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Bridge to Life Ltd. Funding FAQs
What does Bridge to Life Ltd. do?
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. The U.S. based company, headquartered in Northbrook, Illinois, is a leading supplier of preservation solutions worldwide with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, it continues to explore emerging science and preservation technologies.
How much funding has Bridge to Life Ltd. raised?
Bridge to Life Ltd. has raised $166M across 2 rounds on record. The most recent is a Series C of $110M announced in Aug 2026.
When did Bridge to Life Ltd. last raise funding?
Bridge to Life Ltd.'s most recent funding round on record is a Series C of $110M, announced in Aug 2026.
Who has invested in Bridge to Life Ltd.?
Investors on record for Bridge to Life Ltd. include Perceptive Advisors, Soleus Capital, Lauxera Capital Partners, Peter Maag.
Who is the CEO of Bridge to Life Ltd.?
Don Webber is listed as CEO at Bridge to Life Ltd..
Where is Bridge to Life Ltd. headquartered?
Bridge to Life Ltd. is based in Northbrook, Illinois, United States.
How many employees does Bridge to Life Ltd. have?
Bridge to Life Ltd. is in the 101-250 employee band.
When was Bridge to Life Ltd. founded?
Bridge to Life Ltd. was founded in 2005.
How does Bridge to Life Ltd.'s funding compare to other Biotechnology startups?
Bridge to Life Ltd.'s latest round of $110M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bridge to Life Ltd. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bridge to Life Ltd. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.